These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35585163)

  • 1. Combined kinetic analysis of SARS-CoV-2 RNAemia, N-antigenemia and virus-specific antibodies in critically ill adult COVID-19 patients.
    Costa R; Alberola J; Olea B; Gozalbo-Rovira R; Giménez E; Cuevas-Ferrando E; Torres I; Albert E; Carbonell N; Ferreres J; Sánchez G; Rodríguez-Díaz J; Blasco ML; Navarro D
    Sci Rep; 2022 May; 12(1):8273. PubMed ID: 35585163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 N-antigenemia in critically ill adult COVID-19 patients: Frequency and association with inflammatory and tissue-damage biomarkers.
    Olea B; Albert E; Torres I; Gozalbo-Rovira R; Carbonell N; Ferreres J; Poujois S; Costa R; Colomina J; Rodríguez-Díaz J; Blasco ML; Navarro D
    J Med Virol; 2022 Jan; 94(1):222-228. PubMed ID: 34449894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19.
    Bermejo-Martin JF; González-Rivera M; Almansa R; Micheloud D; Tedim AP; Domínguez-Gil M; Resino S; Martín-Fernández M; Ryan Murua P; Pérez-García F; Tamayo L; Lopez-Izquierdo R; Bustamante E; Aldecoa C; Gómez JM; Rico-Feijoo J; Orduña A; Méndez R; Fernández Natal I; Megías G; González-Estecha M; Carriedo D; Doncel C; Jorge N; Ortega A; de la Fuente A; Del Campo F; Fernández-Ratero JA; Trapiello W; González-Jiménez P; Ruiz G; Kelvin AA; Ostadgavahi AT; Oneizat R; Ruiz LM; Miguéns I; Gargallo E; Muñoz I; Pelegrin S; Martín S; García Olivares P; Cedeño JA; Ruiz Albi T; Puertas C; Berezo JÁ; Renedo G; Herrán R; Bustamante-Munguira J; Enríquez P; Cicuendez R; Blanco J; Abadia J; Gómez Barquero J; Mamolar N; Blanca-López N; Valdivia LJ; Fernández Caso B; Mantecón MÁ; Motos A; Fernandez-Barat L; Ferrer R; Barbé F; Torres A; Menéndez R; Eiros JM; Kelvin DJ
    Crit Care; 2020 Dec; 24(1):691. PubMed ID: 33317616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly Sensitive Quantification of Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Sheds Light on its Potential Clinical Value.
    Veyer D; Kernéis S; Poulet G; Wack M; Robillard N; Taly V; L'Honneur AS; Rozenberg F; Laurent-Puig P; Bélec L; Hadjadj J; Terrier B; Péré H
    Clin Infect Dis; 2021 Nov; 73(9):e2890-e2897. PubMed ID: 32803231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Kinetics of SARS-CoV-2 Antibody Development Is Associated with Clearance of RNAemia.
    Wang C; Li Y; Kaplonek P; Gentili M; Fischinger S; Bowman KA; Sade-Feldman M; Kays KR; Regan J; Flynn JP; Goldberg MB; Hacohen N; Filbin MR; Lauffenburger DA; Alter G; Li JZ
    mBio; 2022 Aug; 13(4):e0157722. PubMed ID: 35762593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19.
    Kawasuji H; Morinaga Y; Tani H; Yoshida Y; Takegoshi Y; Kaneda M; Murai Y; Kimoto K; Ueno A; Miyajima Y; Fukui Y; Kimura M; Yamada H; Sakamaki I; Yamamoto Y
    J Med Virol; 2022 Jan; 94(1):147-153. PubMed ID: 34411312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2-reactive IFN-γ-producing CD4
    Olea B; Albert E; Giménez E; Torres I; Amat P; Remigia MJ; Alberola J; Carbonell N; Ferreres J; Blasco ML; Navarro D
    Sci Rep; 2022 Aug; 12(1):14271. PubMed ID: 35995830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019.
    Chen X; Zhao B; Qu Y; Chen Y; Xiong J; Feng Y; Men D; Huang Q; Liu Y; Yang B; Ding J; Li F
    Clin Infect Dis; 2020 Nov; 71(8):1937-1942. PubMed ID: 32301997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of SARS-CoV-2 nucleocapsid antigen from serum can aid in timing of COVID-19 infection.
    Ahava MJ; Kurkela S; Kuivanen S; Lappalainen M; Jarva H; Jääskeläinen AJ
    J Virol Methods; 2022 Apr; 302():114469. PubMed ID: 35051445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients.
    Li L; Liang Y; Hu F; Yan H; Li Y; Xie Z; Huang L; Zhao J; Wan Z; Wang H; Shui J; Cai W; Tang S
    Virology; 2020 Dec; 551():26-35. PubMed ID: 33011520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients.
    Eberhardt KA; Meyer-Schwickerath C; Heger E; Knops E; Lehmann C; Rybniker J; Schommers P; Eichenauer DA; Kurth F; Ramharter M; Kaiser R; Holtick U; Klein F; Jung N; Di Cristanziano V
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32962125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Frequency of SARS-CoV-2 RNAemia and Association With Severe Disease.
    Hogan CA; Stevens BA; Sahoo MK; Huang C; Garamani N; Gombar S; Yamamoto F; Murugesan K; Kurzer J; Zehnder J; Pinsky BA
    Clin Infect Dis; 2021 May; 72(9):e291-e295. PubMed ID: 32965474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining predictive markers for severe COVID-19: Torquetenovirus DNA load and SARS-CoV-2 RNAemia.
    Solis M; Gallais F; Garnier-Kepka S; Lefebvre N; Benotmane I; Ludes PO; Castelain V; Meziani F; Caillard S; Collange O; Fafi-Kremer S
    J Clin Virol; 2022 Mar; 148():105120. PubMed ID: 35227970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-antigenemia detection by a rapid lateral flow test predicts 90-day mortality in COVID-19: A prospective cohort study.
    Almansa R; Eiros JM; de Gonzalo-Calvo D; Postigo T; Ortega A; Lopez-Izquierdo R; Moncusí-Moix A; Gort-Paniello C; Dominguez-Gil M; de la Fuente A; González-González L; Luis-García T; García-Mateo N; Tedim AP; Rodríguez-Jara F; Jorge N; González J; Torres G; Gutiérrez-Pérez ON; Villegas MJ; Campo S; Ayllon E; Ruiz Albi T; de Frutos Arribas J; Arroyo Domingo A; Abadia-Otero J; Gómez Barquero J; Trapiello W; Garcia Frade LJ; Inglada L; Del Campo F; Bermejo-Martin JF; Barbé F; Torres A
    Clin Microbiol Infect; 2022 Oct; 28(10):1391.e1-1391.e5. PubMed ID: 35654316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of high SARS-CoV-2 RNAemia with diabetes and mortality in critically ill COVID-19 patients.
    Monchi M; Bruneau T; Jochmans S; Veyer D; Pitsch A; Ellrodt O; Picque M; Taly V; Sy O; Mazerand S; Diamantis S; Péré H
    iScience; 2022 May; 25(5):104075. PubMed ID: 35309726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of viral load and antibody response in relation to COVID-19 severity.
    Wang Y; Zhang L; Sang L; Ye F; Ruan S; Zhong B; Song T; Alshukairi AN; Chen R; Zhang Z; Gan M; Zhu A; Huang Y; Luo L; Mok CKP; Al Gethamy MM; Tan H; Li Z; Huang X; Li F; Sun J; Zhang Y; Wen L; Li Y; Chen Z; Zhuang Z; Zhuo J; Chen C; Kuang L; Wang J; Lv H; Jiang Y; Li M; Lin Y; Deng Y; Tang L; Liang J; Huang J; Perlman S; Zhong N; Zhao J; Malik Peiris JS; Li Y; Zhao J
    J Clin Invest; 2020 Oct; 130(10):5235-5244. PubMed ID: 32634129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On-admission SARS-CoV-2 RNAemia as a single potent predictive marker of critical condition development and mortality in COVID-19.
    Miki S; Sasaki H; Horiuchi H; Miyata N; Yoshimura Y; Miyazaki K; Matsumura T; Takahashi Y; Suzuki T; Matano T; Kawana-Tachikawa A; Tachikawa N
    PLoS One; 2021; 16(7):e0254640. PubMed ID: 34255796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution and serologic response in SARS-CoV-2 induced ARDS: A cohort study.
    Schlesinger T; Weißbrich B; Wedekink F; Notz Q; Herrmann J; Krone M; Sitter M; Schmid B; Kredel M; Stumpner J; Dölken L; Wischhusen J; Kranke P; Meybohm P; Lotz C
    PLoS One; 2020; 15(11):e0242917. PubMed ID: 33232382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship Between Serum Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid and Organ Damage in Coronavirus 2019 Patients: A Cohort Study.
    Xu D; Zhou F; Sun W; Chen L; Lan L; Li H; Xiao F; Li Y; Kolachalama VB; Li Y; Wang X; Xu H
    Clin Infect Dis; 2021 Jul; 73(1):68-75. PubMed ID: 32720678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma SARS-CoV-2 RNA Levels as a Biomarker of Lower Respiratory Tract SARS-CoV-2 Infection in Critically Ill Patients With COVID-19.
    Jacobs JL; Naqvi A; Shah FA; Boltz VF; Kearney MF; McVerry BJ; Ray P; Schaefer C; Fitzpatrick M; Methé B; Lee JS; Morris A; Mellors JW; Kitsios GD; Bain W
    J Infect Dis; 2022 Dec; 226(12):2089-2094. PubMed ID: 35511031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.